Esperion Therapeutics Inc (ESPR)

ESPR (NASDAQ:Drugs) EQUITY
$49.31
pos +0.00
+0.00%
Today's Range: 48.00 - 50.19 | ESPR Avg Daily Volume: 725,300
Last Update: 09/22/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 293.85%
Open: $0.00
Previous Close: $49.37
52 Week Range: $9.40 - $57.38
Oustanding Shares: 22,593,162
Market Cap: 1,115,424,408
6-Month Chart
TheStreet Ratings Grade for ESPR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 4 3 3
Moderate Buy 0 0 0 0
Hold 3 3 7 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.86 2.40 2.33
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -8.54
Price Earnings Comparisons:
ESPR Sector Avg. S&P 500
-8.54 0.00 36.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
16.54% 254.75% 204.95%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.00 0.00
Net Income 0.00 1.90 0.00
EPS 0.00 0.00 0.00
Earnings for ESPR:
EBITDA -0.08B
Revenue 0.00B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $-1.78 $-1.77 $-7.17 $-6.00
Number of Analysts 7 5 8 8
High Estimate $-1.61 $-1.57 $-6.54 $-4.42
Low Estimate $-1.95 $-1.98 $-7.66 $-9.36
Prior Year $-0.77 $-1.29 $-3.33 $-7.17
Growth Rate (Year over Year) -131.17% -37.36% -115.20% 16.26%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Biotech companies show more energy than the rest of the market Monday.
I'm starting a new periodic feature that will bring you the hottest-trading stocks I see.
Buyers were hesitant to keep pressing as the day wrapped up.
Not a big day of gains, but there is underlying support.
Gloom is gone as likelihood of Fed rate hike fades.
Wal-Mart sets the tone, but selling hasn't been bad enough to kill rally.
Oil- and commodity-related shares perform well.
Only one fund category (of 20) has beaten the S&P 500 over half a decade.
Thin volume likely ahead of holiday weekend.
A flood of supply in a nervous market isn't a good idea.

Columnist Conversations

Spent a good amount of time with PayPal CEO Dan Schulman this week...and came away fully understanding why thi...
Has quietly taken a mini beating over the past few weeks. Might be worth a look on Monday given everything tha...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.